Table 1.
The functions of SMs in RA synovium.
| Cell type | Mediator | Function |
|---|---|---|
| Polarization | ||
| SMs (M1) | TF and pathway: STAT1, IRF5, SOCS1, NF-κB pathway | Proinflammation; glycolysis; iron retention |
| Cytokine: IL-1β, TNF-α, IL-12, IL-23 | ||
| Chemokine: CXCL9/10/11, CCL5 | ||
| Surface marker: MHCII | ||
| SMs (M2) | TF and pathway: STAT6, IRF4, SOCS3, KLF4, c-Myc | Anti-inflammation; oxidative phosphorylation; iron export |
| Cytokine: IL-4, IL-10 | ||
| Chemokine: CCL17/22 | ||
| Surface marker:CD206, CD163,MGL | ||
| Cell-cell communications | ||
| Synovial fibroblasts (SF) | IL-1β, TNF-α | SMs promote SF proliferation. |
| Osteoclasts | IL-1β, IL-6, TNF-α | SMs promote osteoclasts activation. |
| Monocytes | IL-1β, IL-8, TNF-α, CCL2 | SMs recruit monocytes. |
| Neutrophils | IL-1β, IL-8, TNF-α, CCL2 | SMs recruit neutrophils. |
| T cells (Th1 cells) | TNF-α, IL-12 | SMs promote Th1 polarization. |
| T cells (Th17 cells) | IL-23 | SMs promote Th17 polarization. |
| B cells | Immune complex and autoantibody | B cells activate SMs. |